GlassScriptPhysician profile
Prayag Barot
NPI 1366463077
$8,251.29
in general payments reported to CMS, 2019-2025
22 companies · $363 in 2025
The $363 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $25.92 · 2020: $36.32 · 2021: $7,581 · 2022: $11.74 · 2024: $234 · 2025: $363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $597.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $596.52 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $7,580.79 | 2021 | |
| Phathom Pharmaceuticals, INC. | $121.33 | 2025 | Voquezna |
| Ethicon US, LLC | $73.63 | 2020-2025 | Ethicon, Vistaseal |
| Corcept Therapeutics | $50.29 | 2024-2025 | Korlym |
| Conmed Corporation | $41.31 | 2025 | Airseal |
| Tela Bio, INC. | $36.97 | 2024 | Ovitex 2s |
| Kerecis Limited | $34.71 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Convatec INC. | $26.75 | 2025 | |
| Boston Scientific Corporation | $25.92 | 2019 | |
| Integra Lifesciences Corporation | $25.71 | 2024 | Integra, Integra Dermal Regeneration Template, Omnigraft |
| Medtronic, INC. | $24.75 | 2024 | Progrip |
| Becton, Dickinson and Company | $23.85 | 2024 | Bard 3dmax Mesh |
| Distalmotion US | $21.92 | 2025 | Dexter L6 Robot |
| Teleflex LLC | $21.63 | 2025 | Titan Sgs Bailout Chuck |
| Dexcom, INC. | $21.38 | 2025 | Dexcom G6 Transmitter |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Laborie Medical Technologies Corp. | $21.33 | 2024 | |
| Davol INC. | $20.44 | 2025 | Bard 3dmax Mesh |
| Abbvie INC. | $18.33 | 2025 | |
| Lilly USA, LLC | $17.80 | 2025 | Zepbound |
| Vertex Pharmaceuticals Incorporated | $16.58 | 2024 | |
| Vertical Pharmaceuticals, LLC | $13.84 | 2024 | Dsuvia |
| Merit Medical Systems INC | $12.03 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Prayag Barot listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.